MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly

NCT01623232 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped FDA hold on the project

Conditions

Influenza Vaccines
Aged

Interventions

BIOLOGICAL: MAS-1 adjuvant and influenza HA antigen
BIOLOGICAL: standard dose, inactivated trivalent influenza vaccine (TIV)

Sponsor

US Department of Veterans Affairs

Collaborators

[object Object]